Bio Green Med Solution Inc Preferred Stock
BGMSP
BGMSP was delisted on the 20th of March, 2026.
3 hedge funds and large institutions have $100K invested in Bio Green Med Solution Inc Preferred Stock in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 0 closing their positions.
50% more funds holding
Funds holding: 2 → 3 (+1)
22% more capital invested
Capital invested by funds: $82K → $100K (+$18K)
0.08% more ownership
Funds ownership: 3.91% → 3.99% (+0.08%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.69K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BBA
1
Baker Bros. Advisors
New York
| $98K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $2K | +$1.69K | +270 | New |
|
BGMSP Hedge Fund Activity: Q3 2017 in Review
3 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc Preferred Stock (BGMSP) for Q3 2017, worth a combined $100K — up 22% from $82K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BGMSP positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $1.69K.
- 3 institutional investors held Bio Green Med Solution Inc Preferred Stock (BGMSP) as of Q3 2017, up from 2 in Q2 2017.
- Funds reported $100K of Bio Green Med Solution Inc Preferred Stock stock for Q3 2017, up 22% quarter-over-quarter.
- 1 fund opened new Bio Green Med Solution Inc Preferred Stock positions in Q3 2017 and 0 closed out, a net change of +1 holder.
- The largest Bio Green Med Solution Inc Preferred Stock buyer in Q3 2017 was UBS Group, an estimated $1.69K added.
Based on aggregated 13F filings for Q3 2017.